ELIZABETH CHURCH: Open Payments
NPI 1578809000 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 47 payments from 14 companies in 2025. Trend: 2023 $1,088 · 2024 $819 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $225 |
| Teva Pharmaceuticals USA, Inc. | 7 | $139 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| Lundbeck LLC | 4 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Tris Pharma Inc | 1 | $80 |
| Bausch Health US, LLC | 3 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, UZEDY, Onyda XR, INGREZZA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
